At the news
? NEUTRALIMPACT 2/10 CLUSTER filed Aug 6, 2026 at 17:06 ET
Two Guardant Health directors (Ian T. Clark and Manuel Hidalgo Medina) sold a combined $1.60M in open-market shares over two days, primarily from exercised derivatives. The total sale value represents only ~0.007% of GH's $21.9B market cap, a trivial amount that does not signal a material change in insider conviction or company outlook.
- Two directors sold a combined $1.60M in open-market shares (Clark: $1.44M, Hidalgo Medina: $156K).
- Sales represent ~0.007% of GH's $21.9B market cap, well below the 0.1% materiality threshold.
- Both sales were accompanied by derivative exercises (non-cash grants), indicating routine portfolio management.
- No C-suite executives participated; all trades were by directors.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access